ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Baylor College of Medicine
Houston, Estados UnidosPublicacións en colaboración con investigadores/as de Baylor College of Medicine (3)
2020
-
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Journal of Clinical Investigation, Vol. 130, Núm. 9, pp. 4871-4887
2011
-
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Clinical Proteomics, Vol. 8, Núm. 1
2010
-
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
Breast Cancer Research, Vol. 12, Núm. 3